Evidence map›Paper›PMID 26902455›Full record

ArticleScientific reports2016

Diversity between mammalian tolloid proteinases: Oligomerisation and non-catalytic domains influence activity and specificity.

Christopher P Bayley, Hilda D Ruiz Nivia, Rana Dajani, Thomas A Jowitt, Richard F Collins, Heather Rada, Louise E Bird, Clair Baldock

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Christopher P BayleyWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, M13 9PT, UK.
Hilda D Ruiz NiviaWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, M13 9PT, UK.
Rana DajaniWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, M13 9PT, UK.
Thomas A JowittWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, M13 9PT, UK.
Richard F CollinsFaculty of Life Sciences, University of Manchester, Manchester, M13 9PT, UK.
Heather RadaOPPF-UK, Research Complex at Harwell, Rutherford Appleton Laboratory, Oxford, OX11 0FA, UK.
Louise E BirdOPPF-UK, Research Complex at Harwell, Rutherford Appleton Laboratory, Oxford, OX11 0FA, UK.
Clair BaldockWellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, M13 9PT, UK.
University of Manchester · GBResearch Complex at Harwell · GBRutherford Appleton Laboratory · GBWellcome Centre for Cell-Matrix Research · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I012265/1Medical Research Council MR/K018779/1
6 · The paper itself

Abstract

The mammalian tolloid family of metalloproteinases is essential for tissue patterning and extracellular matrix assembly. The four members of the family: bone morphogenetic protein-1 (BMP-1), mammalian tolloid (mTLD), tolloid-like (TLL)-1 and TLL-2 differ in their substrate specificity and activity levels, despite sharing similar domain organization. We have previously described a model of substrate exclusion by dimerisation to explain differences in the activities of monomeric BMP-1 and dimers of mTLD and TLL-1. Here we show that TLL-2, the least active member of the tolloid family, is predominantly monomeric in solution, therefore it appears unlikely that substrate exclusion via dimerisation is a mechanism for regulating TLL-2 activity. X-ray scattering and electron microscopy structural and biophysical analyses reveal an elongated shape for the monomer and flexibility in the absence of calcium. Furthermore, we show that TLL-2 can cleave chordin in vitro, similar to other mammalian tolloids, but truncated forms of TLL-2 mimicking BMP-1 are unable to cleave chordin. However, both the N- and C-terminal non-catalytic domains from all mammalian tolloids bind chordin with high affinity. The mechanisms underlying substrate specificity and activity in the tolloid family are complex with variation between family members and depend on both multimerisation and substrate interaction.

Indexed as

Protein Interaction Domains and MotifsAlternative SplicingAnimalsBone Morphogenetic Protein 1CalciumEnzyme AssaysGene ExpressionGlycoproteinsHEK293 CellsHumansHydrodynamicsIntercellular Signaling Peptides and ProteinsKineticsModels, MolecularProtein BindingProtein MultimerizationBMP1 protein, humanBone Morphogenetic Protein 1CalciumchordinGlycoproteinsIntercellular Signaling Peptides and ProteinsRecombinant ProteinsTLL2 protein, humanTolloid-Like Metalloproteinases

Identifiers

PMID26902455
PMCPMC4763255
OpenAlexW2277068901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.